Dr Andrew Potter

  • MBBS, BMedSc(Hons), FRANZCR
  • Radiation Oncologist
  • Spoken languages English

Overview

Awards received

  • RS Bush Award for Academic Excellence, University of Toronto, 2009

Professional memberships

  • RANZCR
  • ASTRO
  • ESTRO
  • TROG
  • COGNO
  • ANZGOG
  • Member of the ESTRO Radiobiology Course teaching faculty

Publications and affiliations

  • Devlin EJ, Whitford HS, Denson LA, Potter AE. ‘Measuring up’: A comparison of two response expectancy assessment formats completed by men treated with radiotherapy for prostate cancer. J Psychosom Res. 2020;132:109979.
  • Mullin SJ, Lochhead A, Haddad R, Kippen J, Paddon V, Joshua A, Koh K, Potter A, Fogarty GB. Keratoacanthomas following definitive volumetric modulated arc radiotherapy for skin field cancerization. Int J Radiol Radiat Ther. 2019;6(6):225-232.
  • Fogarty GB, Christie D, Potter AE. Volumetric modulated arc therapy (VMAT) for extended skin field cancerisation (ESFC): Radiobiological learnings from unique patient cases. Int J Radiol Radiat Ther. 2019;6(5):156-162.
  • Potter A, Price M, Papworth D, Melven L, Shaw I, Hayles M, Hellyer J, Buman K, Kaminski A, Schlect D, Wong B, Christie D, Izard MA, Holt NE, Fogarty GB. A technique for treating extended skin field cancerisation using volumetric modulated arc therapy. Int J Radiol Radiat Ther. 2019;6(4):111‒119.
  • Devlin EJ, Whitford HS, Denson LA, Potter AE. ‘Just as I expected’: A longitudinal cohort study of the impact of response expectancies on side effect experiences during radiotherapy for prostate cancer. J Pain Symptom Manage. 2019 Feb;57(2):273-281.